A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The XLMTM is caused by mutations in the myotubularin 1 (MTM1) gene, located at Xq28.31”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [31]
In the citing paper
“Furthermore, mounting evidence shows that autophagy is regulated by distinct mechanisms in different cell types [11–26], and these cell type-specific mechanisms underlie the differential vulnerability of separate tissues to autophagy mutations, resulting in heterogenous manifestations of disease.”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“For instance, centronuclear myopathy is caused by mutations in the genes encoding MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“These loss-of-function mutations prevent these enzymes from metabolizing phosphoinositides required for autophagy, thereby disinhibiting autophagy flux and muscle atrophy [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., et al. (1994) · Nature · doi:10.1038/368032a0 · Cited by 1,465
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationProtein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes
Fischer, E. H., Charbonneau, H., & Tonks, N. K. (1991) · Science · doi:10.1126/science.1650499 · Cited by 956
Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.
Uberbacher, E. C., & Mural, R. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11261 · Cited by 652
Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins
Gribskov, M., & Burgess, R. R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.16.6745 · Cited by 445
Hormones, Growth Factors, and Myogenic Differentiation
Florini, J. R., Ewton, D. Z., & Magri, K. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001221 · Cited by 423
Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.
Buckler, A. J., Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.4005 · Cited by 420
Research works printed but not linked: 1
- Lanfranchi, G. et al. Identification of 4,370 expressed sequence tags (ESTs) from a 3′-end specific cDNA library of human skeletal muscle by DNA sequencing and fitter hybridization. Genome Res. (in the press).
Cited by
Items 401–500 of 654
PI3P-dependent regulation of cell size and autophagy by phosphatidylinositol 5-phosphate 4-kinase
Ghosh, A., Venugopal, A., Shinde, D. D., Sharma, S., Krishnan, M., Mathre, S., Krishnan, H., Saha, S., & Raghu, P. (2023) · Life Science Alliance · doi:10.26508/lsa.202301920 · Cited by 12
“In mammals, in vitro studies have revealed that lipid phosphatases of the myotubularin family have speci fi c activity toward PI3P and PI(3,5)P 2 (Fig 1A) (Laporte et al, 1996; Walker et al, 2001; Schaletzky et al, 2003).”
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00027-3 · Cited by 14
Deletion of both MTM1 and MTMR1 genes in a boy with myotubular myopathy
Zanoteli, E., Laporte, J., Rocha, J. C. C., Kretz, C., Oliveira, A. S. B., Mandel, J., Pérez, A. B. A., Gabbai, A. A., & Buj‐Bello, A. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30574 · Cited by 12
“The disease is caused by mutations in the MTM1 gene, which spans about 100 kb on chromosome Xq28 and is composed of 15 exons [Laporte et al., 1996, 1998].”
BackgroundSelf-citationChojnowski, A., Ravisé, N., Bachelin, C., Depienne, C., Ruberg, M., Brugg, B., Laporte, J., Evercooren, A. B., & Leguern, É. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.018 · Cited by 14
“MTMR2 is the closest homologue of MTM1, which whenmutated causes X-linked myotubular myopathy (Laporte et al., 1996), a severe congenital muscular disorder.”
BackgroundSelf-citationLarge duplication in MTM1 associated with myotubular myopathy
Amburgey, K., Lawlor, M. W., del Gaudio, D., Cheng, Y., Fitzpatrick, C. A., Minor, A., Li, X., Aughton, D. J., Das, S., Beggs, A. H., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.11.010 · Cited by 12
“Currently, mutations in four genes are associated with CNM: dynamin-2 (DNM2) [5], ryanodine receptor (RYR1) [6], amphiphysin 2 (BIN1) [7] and myotubularin (MTM1) [8].”
BackgroundUnconventional roles for membrane traffic proteins in response to muscle membrane stress
Vassilopoulos, S. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.02.007 · Cited by 12
Samsó, P., Koch, P. A., Posor, Y., Lo, W., Belabed, H., Nazaré, M., Laporte, J., & Haucke, V. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202236119 · Cited by 12
Self-citationGeneral Anesthesia for a Patient with Centronuclear (Myotubular) Myopathy
Gottschalk, A., Heiman-Patterson, T. D., de Quevedo, R., & Quinn, P. D. (1998) · Anesthesiology · doi:10.1097/00000542-199810000-00026 · Cited by 12
Identification of genes induced by rapid intraoperative tissue expansion in mouse skin
Zhu, Y., Luo, J., Barker, J. S., Hochberg, J., Cilento, E. V., & Reilly, F. (2001) · Archives of Dermatological Research · doi:10.1007/s00403-001-0277-8 · Cited by 13
“Mutation of myotubularin causes X-linked myotubular myopathy characterized by severe hypotonia and generalized muscle weakness (Laporte et al. 1996, 2000).”
BackgroundRatan, S. K., Sharma, A., Kapoor, S., Polipalli, S. K., Dubey, D., Mishra, T. K., Sinha, S. K., & Agarwal, S. K. (2016) · Pediatric Surgery International · doi:10.1007/s00383-016-3856-7 · Cited by 14
A dog model for centronuclear myopathy carrying the most common DNM2 mutation
Böhm, J., Barthélémy, I., Landwerlin, C., Blanchard‐Gutton, N., Relaix, F., Blot, S., Laporte, J., & Tiret, L. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049219 · Cited by 12
“CNM is a genetically heterogenous disease with X-linked, autosomal-dominant and autosomal-recessive forms essentially and respectively caused by mutations in MTM1 , DNM2 and BIN1 (Bitoun et al., 2005; Bohm et al., 2014; Laporte et al., 1996; Nicot et al., 2007).”
Self-citationLaing, N. G., Sewry, C. A., & Lamont, P. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)86001-5 · Cited by 12
Muscular Dystrophies and Myopathies in Arab Populations
Salih, M. A. M. (2010) · Springer eBooks · doi:10.1007/978-3-642-05080-0_6 · Cited by 13
Phosphoinositides in New Spaces
Davies, E. M., Mitchell, C. A., & Stenmark, H. (2023) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041406 · Cited by 13
Uncovering the BIN1-SH3 interactome underpinning centronuclear myopathy
Zámbó, B., Edelweiss, E. F., Morlet, B., Négroni, L., Pajkos, M., Dosztányi, Z., Østergaard, S., Travé, G., Laporte, J., & Gógl, G. (2024) · eLife · doi:10.7554/elife.95397 · Cited by 12
Self-citationHu, C., Li, Y., Li, L., Zhang, N., & Zheng, X. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae656 · Cited by 12
Neuromuscular Features in XL-MTM Carriers
Franken, D. K., Bouman, K., Reumers, S. F. I., Braun, F., Spillane, J. E., Pennings, M., Houwen, S. L. S., Erasmus, C. E., Schara, U., Kamsteeg, E., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201084 · Cited by 11
Longo, G., Russo, S., Novelli, G., Sangiuolo, F. C., & D’Apice, M. R. (2015) · Clinical Genetics · doi:10.1111/cge.12674 · Cited by 11
“719T>A was located in exon 9, encoding for a region conserved throughout evolution (5).”
BackgroundSPEG binds with desmin and its deficiency causes defects in triad and focal adhesion proteins
Luo, S., Li, Q., Lin, J., Murphy, Q., Marty, I., Zhang, T., Kazerounian, S., & Agrawal, P. B. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa276 · Cited by 11
I-proteins – a proposed switch in myotubularin function
Clague, M. J., Dove, S. K., & Barr, F. A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.005 · Cited by 11
Lim, H. J., Joo, S., Oh, S., Jackson, J. D., Eckman, D. M., Bledsoe, T., Pierson, C. R., Childers, M. K., Atala, A., & Yoo, J. J. (2014) · Cell Transplantation · doi:10.3727/096368914x683494 · Cited by 11
“Myotubularin, the protein encoded by the MTM1 gene, is a ubiquitously expressed phosphoinositide phosphatase implicated in intracellular vesicle trafficking and autophagy (23,32,38).”
BackgroundMuscle function and dysfunction in health and disease
Huh, M. S., Smid, J. K., & Rudnicki, M. A. (2005) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20045 · Cited by 11
Ziemian, M., Szmydtka, J., Snoch, W., Milner, S., Wojciechowski, S., Dłuszczakowska, A., Chojnowski, J. W., Pallach, Z., Żamojda, K., Węgrzyn, G., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167972 · Cited by 11
Wallgren‐Pettersson, C., & Laing, N. G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.017 · Cited by 11
Drouet, A., Ollagnon‐Roman, E., Streichenberger, N., Biancalana, V., Cossée, M., Guilloton, L., & Petiot, P. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2007.08.008 · Cited by 10
Vasli, N., Laugel, V., Böhm, J., Lannes, B., Biancalana, V., & Laporte, J. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.256 · Cited by 10
Self-citationYu, X., Ma, J., Lin, F. W., Zhao, W., Fu, X., & Zhao, Z. J. (2012) · BMC Cell Biology · doi:10.1186/1471-2121-13-28 · Cited by 11
“For example, mutations in MTM1, the founding member of this family, cause X-linked myotubular myopathy (XLMTM), a severe congenital muscular disorder, while mutations in MTMR2 and MTMR13 are associated with Charcot-Marie-Tooth disease [9-11].”
BackgroundKlein, C. J., & Dyck, P. J. B. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50076-4 · Cited by 13
Felice, K. J., Whitaker, C. H., & Wu, Q. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.02.002 · Cited by 10
Characterization of a novel zebrafish model of SPEG -related centronuclear myopathy
Espinosa, K. G., Geissah, S., Groom, L. A., Volpatti, J. R., Scott, I. C., Dirksen, R. T., Zhao, M., & Dowling, J. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049437 · Cited by 10
“CNM is a genetic disease, caused by pathogenic variants in at least five genes: X-linked recessive CNM caused by myotubularin 1 ( MTM1 ) (Laporte et al., 1996), autosomal-dominant CNM caused by dynamin 2 ( DNM2 ) (Bitoun et al., 2005), and autosomal-recessive forms of CNM caused by bridging…”
A benign congenital myopathy in an inbred Samaritan family
Lev, D., Sadeh, M., Watemberg, N. M., Dabby, R., Vinkler, C., Ginzberg, M., & Lerman‐Sagie, T. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2006.06.003 · Cited by 10
Congenital and Other Structural Myopathies
Dowling, J. J., North, K. N., Goebel, H. H., & Beggs, A. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00028-7 · Cited by 12
An Emerging Role for PI5P in T Cell Biology
Nunès, J. A., & Guittard, G. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00080 · Cited by 9
“Overexpression enhance PI5P pool in Jurkat T cells Laporte et al. (1996), Tronchere et al. (2004) MTMR2, 3, 6 PI3P, PI(3,5)P2 Ubiquitous Cyt., PM?”
BackgroundHedberg‐Oldfors, C., Visuttijai, K., Topa, A., Tulinius, M., & Oldfors, A. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.05.004 · Cited by 9
Dominant Centronuclear Myopathy with Early Childhood Onset due to a Novel Mutation in BIN1
Kouwenberg, C. V., Böhm, J., Erasmus, C. E., van Balken, I., Vos, S. H., Küsters, B., Kamsteeg, E., Biancalana, V., Koch, C., Dondaine, N., et al. (2017) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-170238 · Cited by 9
Self-citationShimizu, S., Sakamoto, S., Fukuda, A., Yanagi, Y., Uchida, H., Takeda, M., Yamada, Y., Nakano, N., Yoshioka, T., & Kasahara, M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15978 · Cited by 9
Buono, S., Monseur, A., Menuet, A., Robé, A., Koch, C., Laporte, J., Thielemans, L. A., Depla, M., & Cowling, B. S. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049284 · Cited by 9
“Myotubular myopathy [also called X-linked centronuclear myopathy (CNM), XLCNM, XLMTM; OMIM 310400] is due to mutations in the phosphoinositide phosphatase myotubularin (MTM1) (Laporte et al., 1996).”
Self-citationX-linked Myotubular Myopathy in a Family with Two Infant Siblings: A Case withMTM1Mutation
Jeon, J. H., Namgung, R., Park, M. S., Park, K. I., Lee, C., Lee, J., & Kim, S. H. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.3.547 · Cited by 9
Garibaldi, M., Böhm, J., Fattori, F., Koch, C., Surace, C., Ottaviani, P., Laschena, F., Laporte, J., Bertini, E., Antonini, G., et al. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150125 · Cited by 11
“myotubularin gene mutations (MTM1) [2, 3], autosomal dominant early onset CNM with frequent and distinctive ‘radiating sarcoplasmic strands’ (RSS) (“spoke-of-wheels”) is linked to dynamin-2 (DNM2) [4], and autosomal recessive and dominant CNM with particular ‘central nuclei clustering’ is caused by mutations in the ge…”
Self-citationDetection of Myotubularin Phosphatases Activity on Phosphoinositides in vitro and ex vivo
Rohde, H. M., Tronchère, H., Payrastre, B., & Laporte, J. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-115-8_18 · Cited by 10
Self-citationValidity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy
Snyder, J. M., Meisner, A., Mack, D. L., Goddard, M. A., Coulter, I. T., Grange, R. W., & Childers, M. K. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2015.049 · Cited by 11
Wallgren‐Pettersson, C. (2004) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2004.10.007 · Cited by 9
Protein Tyrosine Phosphatases in Human Disease
Mustelin, T. (2007) · Springer eBooks · doi:10.1007/0-387-34132-3_5 · Cited by 9
Forme inhabituelle de bon pronostic de la myopathie myotubulaire liée à l’X
Chanzy, S., Routon, M. C., Moretti, S., de Gennes, C., & Mselati, J. C. (2003) · Archives de Pédiatrie · doi:10.1016/s0929-693x(03)00287-2 · Cited by 9
A rare case of centronuclear myopathy with DNM2 mutation: genotype phenotype correlation
Ghorbani-Aghbolaghi, A., & Lechpammer, M. (2017) · Autopsy and Case Reports · doi:10.4322/acr.2017.020 · Cited by 9
Katsumata, N., Tanae, A., Shinagawa, T., Nagashima‐Miyokawa, A., Shimizu, M., Yasunaga, T., Tanaka, T., & Hibi, I. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:4<295::aid-humu7>3.0.co;2-6 · Cited by 1
Regulation of phosphoinositide metabolism in Apicomplexan parasites
Arabiotorre, A., Bankaitis, V. A., & Grabon, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1163574 · Cited by 9
Muscle Involvement and Restricted Disorders
Darras, B. T., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00033-8 · Cited by 9
X-linked recessive myotubular myopathy withMTM1mutations
Han, Y.-M., Kwon, K.-A., Lee, Y., Nam, S., Park, K., Byun, S. Y., Kim, G.-H., & Yoo, H. (2013) · Korean Journal of Pediatrics · doi:10.3345/kjp.2013.56.3.139 · Cited by 8
Exclusion of mutations in the MTMR1 gene as a frequent cause of X‐linked myotubular myopathy
Copley, L. M., Zhao, W. D., Kopacz, K., Herman, G. E., Kioschis, P., Poustka, A., Taudien, S., & Platzer, M. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10135 · Cited by 8
Self-citationBöhm, J., Vasli, N., Maurer, M., Cowling, B. S., Shelton, G. D., Kreß, W., Toussaint, A., Prokic, I., Schara, U., Anderson, T. J., et al. (2013) · PLoS Genetics · doi:10.1371/annotation/22ca13f1-1ce9-4bb5-9c9e-98670f7c4240 · Cited by 8
Self-citationThe Genetics of Strabismus and Associated Disorders
Heidary, G., Traboulsi, E. I., & Engle, E. C. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0042 · Cited by 7
Neuromuscular Disorders: Muscle Involvement and Restricted Disorders
Volpe, J. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3995-2.10019-6 · Cited by 10
A mutation in MTM1 causes X-Linked myotubular myopathy in Boykin spaniels
Olby, N. J., Friedenberg, S. G., Meurs, K. M., DeProspero, D. J., Guevar, J., Lau, J., Yost, O. L., Guo, L. T., & Shelton, G. D. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.02.021 · Cited by 7
Satellite cells deficiency and defective regeneration in dynamin 2‐related centronuclear myopathy
de Almeida, C., Bitoun, M., & Vainzof, M. (2021) · The FASEB Journal · doi:10.1096/fj.202001313rrr · Cited by 8
Yoo, K.-Y., Son, J. Y., Lee, J. U., Shin, W., Im, D.-W., Kim, S. J., Ryu, S. E., & Heo, Y.-S. (2015) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s139900471500927x · Cited by 9
“…gene (MTM1) was initially identified as a gene that is mutated in most patients with X-linked myotubular myopathy, a fatal congenital muscle disease characterized by centrally placed nuclei in muscle fibres and defective muscle-cell development (Laporte et al., 1996, 2000; Spiro et al., 1966).”
Background58th ENMC Workshop: Myotubular Myopathy, 20–22 March, 1998, Naarden, The Netherlands
Wallgren‐Pettersson, C. (1998) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00076-5 · Cited by 7
Sleep in pediatric neuromuscular disorders
Pascoe, J. E., Zygmunt, A., Ehsan, Z., & Gurbani, N. S. (2023) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2023.101092 · Cited by 6
Potential compensatory mechanisms preserving cardiac function in myotubular myopathy
Simon, A., Diedhiou, N., Reiss, D. J., Goret, M., Grandgirard, E., & Laporte, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05512-9 · Cited by 6
Self-citationKaur, S., Sang, Y., & Aballay, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101614 · Cited by 7
“Extensive clinical and genetic data have linked mutations in MTMRs with Charcot-Marie-Tooth disease (41) and myotubular myopathy (42), characterized by muscle weakness and impairment in the maturation of muscle fibers.”
BackgroundThe myopathology of floppy and hypotonic infants in Singapore
Premasiri, M. K., & Lee, Y.-S. (2003) · Pathology · doi:10.1080/00313020310001602648 · Cited by 6
“The most severe is the X-linked form due to mutation of a gene at X-q28.(11) As the muscle fibres with central nuclei bear a striking resemblance to the myotubes of fetal muscles, this muscle disorder has also been referred to as myotubular myopathy and an arrest in development of the muscle at the cellular level was…”
BackgroundChaudhari, T., Todd, D. A., Kent, A. L., Dopita, B., Hallam, L. A., Freckmann, M., & Johnston, H. M. (2010) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2010.01737.x · Cited by 6
Muscle fiber immaturity and inactivity reduce myonecrosis in duchenne muscular dystrophy
Kimura, S., Sugino, S., Ohtani, Y., Matsukura, M., Nishino, I., Ikezawa, M., Sakata, A., Kondo, Y., Yoshioka, K., Huard, J., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440618 · Cited by 6
Two Cases of X-Linked Myotubular Myopathy with NovelMTM1Mutations
Lee, E. H., Yum, M., Park, S. J., Lee, B. H., Kim, G.-H., Yoo, H., & Ko, T. (2013) · Journal of Clinical Neurology · doi:10.3988/jcn.2013.9.1.57 · Cited by 6
Phosphoinositide phosphatases: Modifiers of phosphoinositide signaling in health and disease
Davies, E. M., Jones, E. I., Ooms, L. M., Gurung, R., McGrath, M. J., & Mitchell, C. A. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159652 · Cited by 8
Exon skipping peptide-conjugated morpholinos downregulate dynamin 2 to rescue centronuclear myopathy
Moschovaki-Filippidou, F., Neves, J. D. C., Diedhiou, N., Jad, Y. E., Böhm, J., Wood, M. J. A., Varela, M. A., & Laporte, J. (2025) · Brain · doi:10.1093/brain/awaf249 · Cited by 5
Self-citationLi, Q., Lin, J., Luo, S., Schmitz‐Abe, K., Agrawal, R., Meng, M., Moghadaszadeh, B., Beggs, A. H., Liu, X., Perrella, M. A., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13470 · Cited by 6
Bui, M. T., Fernández‐Eulate, G., Evangelista, T., Lacène, E., Brochier, G., Labasse, C., Madelaine, A., Chanut, A., Beuvin, M., Levy-Borsato, F., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01882-0 · Cited by 5
Self-citationNishikawa, A., Iida, A., Hayashi, S., Okubo, M., Oya, Y., Yamanaka, G., Takahashi, I., Nonaka, I., Noguchi, S., & Nishino, I. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.621 · Cited by 5
“2; Laporte et al., 1996; HGMD Professional 2018.1).”
BackgroundInfluentialHuman myotubularin-related protein 9 regulates ER-to-Golgi trafficking and modulates WNT3A secretion
Doubravská, L., Dostál, V., Knop, F. K., Libusová, L., & Macůrková, M. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111709 · Cited by 6
Kraatari‐Tiri, M., Tuominen, H. J., Tuupanen, S., Haapaniemi, T., Moilanen, J. S., & Rahikkala, E. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.104040 · Cited by 5
Structural rationale to understand the effect of disease-associated mutations on Myotubularin
Bhattacharyya, T., Ghosh, A., Verma, S., Raghu, P., & Sowdhamini, R. (2023) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2023.100100 · Cited by 5
Myotubularin MTM1 Involved in Centronuclear Myopathy and its Roles in Human and Yeast Cells
Craene, J. D. (2015) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000116 · Cited by 6
“9 kb transcript was detected in many tissues including hart, brain, placenta, liver, muscles and pancreas [6,7].”
BackgroundLe support anatomique de la contraction musculaire
Rigoard, P., Bauché, S., Buffenoir, K., Giot, J., Faure, J., Scépi, M., Richer, J.-P., Lapierre, F., & Wager, M. (2009) · Neurochirurgie · doi:10.1016/j.neuchi.2008.05.006 · Cited by 5
Mutations de l’amphiphysine 2 (BIN1) dans les myopathies centronucléaires récessives
Toussaint, A., Nicot, A.-S., Mandel, J., & Laporte, J. (2007) · médecine/sciences · doi:10.1051/medsci/200723121080 · Cited by 6
“Des mutations dans le gène codant pour la myotubularine (MTM1) sont responsables de la forme liée au chromosome X [2], et des”
BackgroundSelf-citationRomero, N. B., & Laporte, J. (2013) · Wiley eBooks · doi:10.1002/9781118635469.ch13 · Cited by 6
Self-citationFunctions of Nuclear Polyphosphoinositides
Olazabal-Morán, M., González-García, A., & Carrera, A. C. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_219 · Cited by 6
Nigro, G., & Muntoni, F. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)87156-8 · Cited by 5
Characterization and functional studies of a FYVE domain‐containing phosphatase in C. elegans
Ma, J., Zeng, F., Ho, W., Teng, L., Li, Q., Fu, X., & Zhao, Z. J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21752 · Cited by 5
“mutation of hMTM1, the founding member of the MTM subfamily enzymes, is responsible for X-linked recessive myotubular myopathy [Laporte et al., 1996], which is characterized by severe hypotonia and generalized muscle weakness with impaired maturation of muscle fibers in affected newborn males.”
InfluentialChilders, M. K., Beggs, A. H., & Buj‐Bello, A. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.10.01 · Cited by 5
“This devastating congenital muscle disorder results from deficiency of myotubularin, a phosphatidylinositol-3phosphatase required for skeletal muscle function, growth and ultrastructural organization (3-6).”
BackgroundMolecular genetics of inherited peripheral neuropathies: who are the actors?
Meuleman, J., Timmerman, V., Nelis, E., & Jonghe, P. D. (2000) · PubMed · Cited by 5
Ericson, V. R., Spilker, K. A., Tugizova, M., & Shen, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114501 · Cited by 4
“The founding family member, MTM1, was discovered through genetic studies that revealed an association with X-linked myotubular myopathy [16, 18, 19].”
Congenital (Structural) Myopathies
Jungbluth, H., & Wallgren‐Pettersson, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05599-9 · Cited by 5
Bosco, L., Leone, D., Comellas, L. C., Monforte, M., Pane, M., Mercuri, E. M., Bertini, E., D’Amico, A., & Fattori, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810274 · Cited by 4
“Otherwise, missense mutations in the phosphatase domain are expected to inactivate the putative enzymatic activity of myotubularin [10,11], resulting in a clinical picture similar to that seen with nonsense variants, or may instead act by altering protein folding and stability [12].”
BackgroundInterplay between myotubularins and Ca2+ homeostasis
Dai, N., Groenendyk, J., & Michalak, M. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119739 · Cited by 4
INVITED REVIEW - Inherited skeletal muscle disorders
N. G. Laing, F. L. M. (1999) · Annals of Human Biology · doi:10.1080/030144699282435 · Cited by 4
Omotobara-Yabe, T., Itonaga, T., Kuga, S., Koga, H., Kusaba, T., Nishida, H., Daa, T., Maeda, T., & Ihara, K. (2021) · Brain and Development · doi:10.1016/j.braindev.2021.11.004 · Cited by 4
A double mutation in a patient with X-linked myotubular myopathy
Tachi, N., Kozuka, N., Chiba, S., Miyaji, M., & Watanabe, I. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(01)00244-2 · Cited by 4
“Myotubularin, which is encoded by the MTM1 gene, is a new family of putative tyrosine phosphatases [5].”
BackgroundDementia in a Child with Myotubular Myopathy
McCrea, H. J., Kretz, C., Laporte, J., & Ment, L. R. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.01.005 · Cited by 4
“005 0887-8994/09/$—see front matter the MTM1 gene encoding the myotubularin protein [2].”
Self-citationDes mutations de la dynamine 2 à l’origine de la forme dominante de la myopathie centronucléaire
Bitoun, M., Romero, N. B., & Guicheney, P. (2006) · médecine/sciences · doi:10.1051/medsci/2006222101 · Cited by 4
“Des mutations responsables de la myopathie myotubulaire ont été identifiées dans le gène codant la myotubularine (MTM1), une phospho-inositide phosphatase potentiellement impliquée dans des processus de trafic membranaire [2].”
BackgroundX-Linked Myotubular Myopathy: Report of a Case With Novel Mutation
Hortobágyi, T., Szabó, H., Kovács, K. S., Bódi, I., Bereg, E., Katona, M., Biancalana, V., Túri, S., & Sztriha, L. (2007) · Journal of Child Neurology · doi:10.1177/0883073807301930 · Cited by 4
“It plays a role in cell growth and differentiation through signal transduction regulation.(8,9,11) Without normal amounts and function of myotubularin, the muscle fiber maturation is disturbed with persisting immature fibers in the neonate.”
BackgroundWallgren‐Pettersson, C. (2003) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(03)00044-8 · Cited by 4
Saar, D., Lennartsson, C., Weidner, P., Burgermeister, E., & Kragelund, B. B. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26774 · Cited by 3
X-linked myotubular myopathy: an untreated treatable disease
Martín, C., & Servais, L. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2473430 · Cited by 3
“XLMTM is caused by mutations in the myotubularin (MTM1) gene [6,21].”
Aging in Drosophila melanogaster
Gumeni, S., & Trougakos, I. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11410-2 · Cited by 3
Animal Models for Inherited Muscle Diseases
Smith, B. F., & Wrighten, R. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_1 · Cited by 3
“In humans, causes of centronuclear myopathies include myotubular myopathy (MTM), which can in turn, be broken down into three forms, X-linked MTM, due to defects in myotubularin (MTM1), autosomal recessive MTM due to defects in amphiphysin 2 (Bin1) and autosomal dominant MTM due to defects in dynamin (DNM2) ( Laporte…”
BackgroundCaldwell, K. K., Sosa, M., & Buckley, C. T. (2006) · Cell Communication and Signaling · doi:10.1186/1478-811x-4-2 · Cited by 10
“Myotubularin, which was originally identified as a candidate gene mutated in X-linked myotubular myopathy [84], has been shown to possess PtdIns3P 3-phosphatase activity [85,86].”
Clinical and pathologic aspects of congenital myopathies
Nonaka, I. (2001) · Cited by 3
Ultrastructural study of muscle
Oldfors, A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.010 · Cited by 3
Jungbluth, H., Sewry, C. A., & Muntoni, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00093-0 · Cited by 3
Metadata
- Authors
- Laporte, J., Hu, L. J., Kretz, C., Mandel, J.-L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., & Dahl, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- German Cancer Research Center (DE)
- Uppsala University (SE)
- Venue
- Nature Genetics
- Published
- 1996-06
- Volume
- 13
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1984366092
- Cited by
- 639
- References
- 51
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 26 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 28 · 2013: 35 · 2012: 26
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- X-linked myotubular myopathy, MTM1 gene, positional cloning, frameshift mutation, missense mutations, yeast homolog, hypotonia, signal transduction, conserved protein families
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cloning, Molecular, Genes, Fungal, Humans, Genetic Linkage, Molecular Sequence Data, Muscle Hypotonia, Muscular Diseases, Mutation, Saccharomyces cerevisiae, Tissue Distribution, X Chromosome, Protein Tyrosine Phosphatases, Conserved Sequence, Caenorhabditis elegans, Protein Tyrosine Phosphatases, Non-Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.